Skip to main content

UBS Group AG

Position in NTRA — Natera, Inc.

CIK 1610520 ZURICH, V8

Position in NTRA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$150,312,449
+$65,736,880 QoQ
Shares Held
553,739
+30.9% QoQ
Ownership
0.384%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#44
of 844 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 79% Shared 0% None 21%

Common Shares in NTRA Over Time

Shares Held

Position Value (USD)

Derivatives in NTRA

reported options exposure · as of Mar 31, 2025
CallValue
$707,050
CallShares
5,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,535,472,160 across 44 Diagnostics & Research names. NTRA ranks #10 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NTRA

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $150,312,449 553,739
2026-03-31 $84,575,569 422,899
2025-12-31 $100,537,749 438,857
2025-09-30 $59,156,795 367,502
2025-06-30 $59,412,142 351,676
2025-03-31 $707,050 5,000
2025-03-31 $49,826,658 352,356
2024-12-31 $26,667,217 168,460
2024-09-30 $25,130,258 197,954
2024-06-30 $28,995,837 267,761
2024-03-31 $14,281,570 156,151
2023-12-31 $2,267,568 36,200
2023-12-31 $9,344,132 149,172
2023-09-30 $1,494,410 33,772
2023-06-30 $2,215,294 45,526
2023-03-31 $4,344,494 78,251
2023-03-31 $832,800 15,000
2022-12-31 $5,172,931 128,776
2022-09-30 $2,416,847 55,154
2022-06-30 $1,439,712 40,624
2022-03-31 $4,935,663 121,329
2021-12-31 $1,929,903 20,665
2021-09-30 $4,478,104 40,184
2021-06-30 $5,713,056 50,322
2021-03-31 $3,718,393 36,620
2020-12-31 $5,122,990 51,477
2020-09-30 $1,054,342 14,595
2020-06-30 $1,089,988 21,861
2020-03-31 $271,397 9,089